Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

被引:4
|
作者
Sugai, Fuminobu [1 ]
Kokunai, Yosuke [1 ]
Yamamoto, Yoichi [1 ]
Hashida, Goichi [2 ]
Shimazu, Kengo [2 ]
Mihara, Masahito [1 ]
Inoue, Satoru [2 ]
Sakoda, Saburo [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Neurol D4, Suita, Osaka 5650871, Japan
[2] Osaka Univ Hosp, Rehabil Unit, Osaka 553, Japan
关键词
Pompe disease; Late onset; Muscle volume analyzer; Bioelectric impedance; Handheld dynamometer;
D O I
10.1007/s00415-009-5367-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The muscle volume analyzer (MVA) can predict limb muscle weight based on bioelectric impedance analysis, whereas the conventional handheld dynamometer (HHD) measures muscle strength. In this study, a 26-year-old female on invasive ventilation due to late-onset Pompe disease was treated with enzyme replacement therapy (ERT) for 12 months. MVA measurements demonstrated time-dependent improvement from the baseline compared to HHD measurements, showing remarkably fluctuating muscle strength. Thus, the MVA can be used as an alternative, particularly for patients suffering from severe limb muscle weakness.
引用
收藏
页码:461 / 463
页数:3
相关论文
共 50 条
  • [11] Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease
    Tang, Shan
    Ma, Jiachu
    Meng, Huaxing
    Guo, Junhong
    Cao, Shuyan
    Wang, Binquan
    MEDICINE, 2021, 100 (03) : E24276
  • [12] A meta-analysis of enzyme replacement therapy in late-onset Pompe disease
    Pedroso Junges, Ana Paula
    Dornelles, Alicia Dorneles
    Pereira, Tiago da Veiga
    Krug, Barbara
    Goncalves, Candice
    Doederlein Schwartz, Ida Vanessa
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S84 - S84
  • [13] Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review
    Antonio Toscano
    Benedikt Schoser
    Journal of Neurology, 2013, 260 : 951 - 959
  • [14] Enzyme replacement therapy in late-onset Pompe disease - A systematic literature review
    Toscano, A.
    Schoser, B.
    NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 851 - 851
  • [15] Immunological Challenges in Late-Onset Pompe Disease Treated with Enzyme Replacement Therapy
    Patel, Trusha
    Banugaria, Suhrad
    DeArmey, Stephanie
    Mackey, Joanne
    Kishnani, Priya
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S50 - S50
  • [16] Enzyme replacement therapy with alglucosidase alpha and pregnancy in late-onset Pompe disease
    Santos, M.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 688 - 688
  • [17] Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review
    Toscano, Antonio
    Schoser, Benedikt
    JOURNAL OF NEUROLOGY, 2013, 260 (04) : 951 - 959
  • [18] Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy
    Bhui, Raj
    Spector, Andrew R.
    NEUROMUSCULAR DISORDERS, 2020, 30 (04) : 329 - 330
  • [19] Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease
    Koeberl, Dwight D.
    Austin, Stephanie
    Case, Laura E.
    Smith, Edward C.
    Buckley, Anne F.
    Young, Sarah P.
    Bali, Deeksha
    Kishnani, Priya S.
    FASEB JOURNAL, 2014, 28 (05): : 2171 - 2176
  • [20] Enzyme replacement therapy with Myozyme® in a patient with late-onset Pompe disease:: A case report
    Tylki-Szymanska, A.
    CLINICAL THERAPEUTICS, 2007, 29 : S121 - S122